Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Clinical Dentistry

Journal Scan / Consensus and Guidelines · May 28, 2024

Oral Effects of the Use of Orally Dissolving Buprenorphine for Opioid Use Disorder

The Journal of the American Dental Association


Additional Info

The Journal of the American Dental Association
Orally dissolving buprenorphine for opioid use disorder linked to caries
J Am Dent Assoc 2024 Apr 30;[EPub Ahead of Print], SL Segelnick, MA Weinberg

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading